Pelthos Therapeutics Inc

Chart & performance

D1W1MN

P/E

—

P/S

—

EPS

Div yield, %

—

Shrs. gr., 5y

—

Rev. gr., 5y

Revenues

Net income

CFO

No notes on this company yet

Write a private note on this company, for your eyes only

Peter Greenleaf

Chairman of the Board · since 2025

Scott Plesha

President, Chief Executive Officer, Director · since 2025

Chief Financial Officer, Treasurer, Company Secretary · since 2025

Sai Rangarao

Chief Commercial Officer · since 2024

Director · since 2025

Richard Baxter

Independent Director · since 2025

Ezra Friedberg

Independent Director · since 2021

Richard Malamut

Independent Director · since 2023

Matthew Pauls

Independent Director · since 2025

URL

IPO date

Feb 16, 2024

Employees

Domiciled in

Incorporated in

No data to show